Workflow
体检
icon
Search documents
美年健康: 公司董事会关于本次交易信息公布前20个交易日公司股票价格波动情况的说明
Zheng Quan Zhi Xing· 2025-07-11 13:13
美年大健康产业控股股份有限公司 董事会关于本次交易信息公布前 20 个交易日 公司股票价格波动情况的说明 美年大健康产业控股股份有限公司(以下简称"公司")拟通过发行股份的方 式购买交易对方持有的衡阳美年健康体检中心有限公司 84.00%股权、宁德美年 大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00%股 权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管理 有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年健 康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 健健康管理有限公司 47.37%少数股权、广州花都区美年大健康管理有限公司 大健康管理有限公司 49.00%少数股权、吉林市昌邑区美年大健康科技管理有限 公司 48.05%少数股权(以下简称"本次交易")。 综上,在剔除大盘因素和同行业板块因素影响后,公司股价在本次重大事项 披露前 20 个交易日内累计涨跌幅未超过 20%,不存在异常波动的情况。 特此说 ...
美年健康: 公司董事会关于本次交易构成关联交易的说明
Zheng Quan Zhi Xing· 2025-07-11 13:13
美年大健康产业控股股份有限公司 董 事 会 二〇二五年七月十一日 根据《上市规则》,上市公司董事会审议本次交易相关议案时,关联董事已 回避表决;上市公司后续在召开董事会、股东大会审议相关议案时,关联董事、 关联股东将回避表决。 特此说明。 美年大健康产业控股股份有限公司 董事会关于本次交易构成关联交易的说明 美年大健康产业控股股份有限公司(以下简称"上市公司")拟通过发行股份 的方式购买交易对方持有的衡阳美年健康体检中心有限公司 84.00%股权、宁德 美年大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00% 股权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管 理有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年 健康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 健健康管理有限公司 47.37%少数股权、广州花都区美年大健康管理有限公司 大健康管理有限公司 49.00%少数股权、吉林市昌邑区美年大健康科技管理 ...
美年健康: 公司董事会关于评估机构的独立性、评估假设前提的合理性、评估方法与评估目的的相关性及评估定价的公允性的说明
Zheng Quan Zhi Xing· 2025-07-11 13:13
Core Viewpoint - The company intends to acquire significant equity stakes in multiple health management and medical examination companies through a share issuance, with a focus on ensuring the independence and fairness of the asset evaluation process [1][2][3] Group 1: Transaction Overview - The company plans to purchase 84% of Hunan Meinian Health Examination Center, 81% of Ningde Meinian Health Management, 75% of Yantai Meinian Health Management, and several other stakes in various health management companies [1] - The total stakes being acquired include significant minority interests in several companies, indicating a broad expansion strategy in the health management sector [1] Group 2: Evaluation Process - The company has engaged Jinzheng (Shanghai) Asset Appraisal Co., Ltd. as the asset evaluation agency, which is compliant with the Securities Law and has the necessary qualifications and experience [2] - The evaluation is based on a reference date of March 31, 2025, and aims to assess the total equity value of the target companies [2] Group 3: Evaluation Independence and Assumptions - The evaluation agency is independent, with no existing relationships or conflicts of interest with the company or the transaction parties, ensuring an unbiased assessment [2] - The assumptions set by the evaluation agency are reasonable and comply with national laws and market practices, reflecting the actual conditions of the assets [2] Group 4: Evaluation Methods and Fairness - The evaluation utilized both the income approach and asset-based approach, ultimately relying on the income approach for the final valuation of the equity [3] - The evaluation process adhered to principles of independence, objectivity, and fairness, resulting in a valuation that accurately reflects the market value of the assets as of the evaluation date [3] - The transaction pricing is based on the evaluation results, ensuring fairness and reasonableness, protecting the interests of the company and its minority shareholders [3]
美年健康: 第九届董事会独立董事专门会议第四次会议审核意见
Zheng Quan Zhi Xing· 2025-07-11 13:13
Core Viewpoint - The independent directors of Meinian Onehealth Healthcare Holdings Co., Ltd. have approved a series of proposals regarding the acquisition of equity stakes in multiple companies through a share issuance, which is expected to enhance the company's business structure and profitability [1][2][3]. Group 1: Approval of Proposals - The independent directors have reviewed and approved the proposal for the company to issue shares for asset acquisition, confirming compliance with relevant laws and regulations [1]. - The transaction plan for issuing shares to purchase assets and related party transactions has been deemed reasonable and operable, benefiting the company's business structure and shareholder interests [2]. - The independent directors have also approved the draft report related to the share issuance for asset acquisition, affirming its compliance with legal requirements [2]. Group 2: Transaction Characteristics - The transaction involves acquiring stakes in 11 companies, including Hengyang Meinian Health Checkup Center Co., Ltd., and minority stakes in 5 subsidiaries, including Zhengzhou Meijian Health Management Co., Ltd. [1]. - The transaction is classified as a related party transaction due to the involvement of a company controlled by the actual controller of Meinian [3]. - It has been confirmed that the transaction does not constitute a major asset restructuring as the assets involved do not exceed 50% of the company's relevant financial metrics [4]. Group 3: Compliance and Procedures - The independent directors have confirmed that the transaction adheres to the regulatory requirements for major asset restructuring and does not involve any recent changes in control [4][5]. - The company has fulfilled all necessary legal procedures and submitted valid legal documents for the transaction [7]. - The evaluation agency selected for the transaction has been deemed independent, and the valuation methods used are considered reasonable and fair [7][9]. Group 4: Financial Aspects - The total transaction price for the equity stakes is approximately 427.78 million yuan [9]. - The company has conducted an analysis of the impact of the transaction on immediate returns and has proposed measures to mitigate any potential dilution of returns [8]. Group 5: Authorization and Future Steps - The board of directors has requested authorization from the shareholders' meeting to handle all matters related to the transaction, including adjustments to the transaction plan and execution of necessary agreements [10].
美年健康: 粤开证券股份有限公司关于交易方案调整不构成重组方案重大调整的核查意见
Zheng Quan Zhi Xing· 2025-07-11 13:13
粤开证券股份有限公司 关于交易方案调整不构成重组方案重大调整的核查意见 美年大健康产业控股股份有限公司(以下简称"美年健康"、"上市公司") 拟通过发行股份的方式购买衡阳美年健康体检中心有限公司(以下简称"衡阳美 年")84.00%股权、宁德美年大健康管理有限公司(以下简称"宁德美年")81.00% 股权、烟台美年大健康体检管理有限公司(以下简称"烟台美年")75.00%股权、 烟台美年福田健康体检管理有限公司(以下简称"烟台美年福田")49.00%股权、 武汉美慈奥亚科技管理有限公司(以下简称"武汉奥亚")52.81%股权、三明美 年大健康管理有限公司(以下简称"三明美年")85.00%股权、肥城美年健康管 理有限公司(以下简称"肥城美年")90.00%股权、德州美年大健康体检管理有 限公司(以下简称"德州美年")84.00%股权、连江美年大健康管理有限公司(以 下简称"连江美年")82.00%股权、沂水美年大健康体检管理有限公司(以下简 称"沂水美年")80.50%股权、山东美铭奥亚健康咨询有限公司(以下简称"山 东奥亚")92.35%股权及控股子公司郑州美健健康管理有限公司(以下简称"郑 州美健")47 ...
美年健康: 粤开证券股份有限公司关于本次交易相关主体不存在《上市公司监管指引第7号——上市公司重大资产重组相关股票异常交易监管》第十二条和《深圳证券交易所上市公司自律监管指引第8号——重大资产重组》第三十条规定情形的核查意见
Zheng Quan Zhi Xing· 2025-07-11 13:13
粤开证券股份有限公司 二条和《深圳证券交易所上市公司自律监管指引第 8 号 ——重大资产重组》第三十条规定情形的核查意见 美年大健康产业控股股份有限公司(以下简称"美年健康"、"上市公司") 拟通过发行股份的方式购买衡阳美年健康体检中心有限公司84.00%股权、宁德美 年大健康管理有限公司81.00%股权、烟台美年大健康体检管理有限公司75.00% 股权、烟台美年福田健康体检管理有限公司49.00%股权、武汉美慈奥亚科技管理 有限公司52.81%股权、三明美年大健康管理有限公司85.00%股权、肥城美年健康 管理有限公司90.00%股权、德州美年大健康体检管理有限公司84.00%股权、连江 美年大健康管理有限公司82.00%股权、沂水美年大健康体检管理有限公司80.50% 股权、山东美铭奥亚健康咨询有限公司92.35%股权及控股子公司郑州美健健康管 理有限公司47.37%少数股权、广州花都区美年大健康管理有限公司49.00%少数 股权、安徽美欣健康管理咨询有限公司42.46%少数股权、淄博美年大健康管理有 限公司49.00%少数股权、吉林市昌邑区美年大健康科技管理有限公司48.05%少 数股权(以下简称"本次 ...
美年健康: 粤开证券股份有限公司关于本次交易符合《上市公司监管指引第9号——上市公司筹划和实施重大资产重组的监管要求》第四条规定的核查意见
Zheng Quan Zhi Xing· 2025-07-11 13:13
营所需的相应资质,标的资产的过户不涉及立项、环保、行业准入、用地、规划、 建设施工等有关报批事项。本次交易涉及的有关审批事项已在本报告书中详细披 露,并对本次交易无法获得批准或核准的风险作出了特别提示; 转让的情形;标的公司不存在出资不实或者影响其合法存续的情况,在相关法律 程序和先决条件得到适当履行和满足的情形下,标的资产过户至公司名下不存在 实质性法律障碍; 与关联人保持独立,符合中国证监会关于上市公司独立性的相关规定。本次交易 有利于提高公司资产的完整性,有利于公司在人员、采购、生产、销售、知识产 权等方面继续保持独立; 大不利变化;有利于上市公司突出主业、增强抗风险能力;有利于上市公司增强 独立性,不会导致新增重大不利影响的同业竞争,以及严重影响独立性或者显失 公平的关联交易。 粤开证券股份有限公司 关于本次交易符合《上市公司监管指引第 9 号——上市公 司筹划和实施重大资产重组的监管要求》第四条规定的核 查意见 美年大健康产业控股股份有限公司(以下简称"美年健康"、"上市公司") 拟通过发行股份的方式购买衡阳美年健康体检中心有限公司84.00%股权、宁德美 年大健康管理有限公司81.00%股权、烟台 ...
美年健康: 美年大健康产业控股股份有限公司拟发行股份购买资产所涉及的武汉美慈奥亚科技管理有限公司股东全部权益价值资产评估报告
Zheng Quan Zhi Xing· 2025-07-11 13:13
本资产评估报告依据中国资产评估准则编制 美年大健康产业控股股份有限公司拟发行股份购买资产所涉及的 武汉美慈奥亚科技管理有限公司股东全部权益价值 资产评估报告 金证评报字【2025】第 0382 号 (共一册,第一册) 金证(上海)资产评估有限公司 证评报字【2025】第 0382 号 资产评估报告 目 录 金证评报字【2025】第 0382 号 资产评估报告 声 明 一、本资产评估报告依据财政部发布的资产评估基本准则和中国资产评估协会发布的 资产评估执业准则和职业道德准则编制。 二、委托人或者其他资产评估报告使用人应当按照法律、行政法规规定及本资产评估 报告载明的使用范围使用资产评估报告;委托人或者其他资产评估报告使用人违反前述规 定使用资产评估报告的,本资产评估机构及资产评估师不承担责任。 本资产评估报告仅供委托人、资产评估委托合同中约定的其他资产评估报告使用人使 用;除此之外,其他任何机构和个人不能成为资产评估报告的使用人。 本资产评估机构及资产评估师提示资产评估报告使用人应当正确理解和使用评估结论, 评估结论不等同于评估对象可实现价格,评估结论不应当被认为是对评估对象可实现价格 的保证。 三、本资产评估 ...
北京发布96项地方标准 首次制定69项
Group 1 - The Beijing Municipal Government has released 96 local standards, including 69 new and 27 revised standards, aimed at improving various sectors [1] - The "Health Examination Quality Control Specification" is the first health examination standard collaboratively developed by Beijing, Tianjin, and Hebei, focusing on quality control in health examination services [1] - The standard emphasizes comprehensive quality control throughout the health examination process, including pre-examination, during examination, and post-examination phases, enhancing service quality and safety in the region [1] Group 2 - The "Electric Vehicle Charging Infrastructure Planning and Design Standard" mandates that 100% of new residential projects must include charging infrastructure, optimizing the planning and design of charging facilities [2] - This standard aims to improve the efficiency of parking resources and charging facilities by aligning charging characteristics with travel patterns in different public building contexts [2] - The "Food Safety Management Specification for Large Events" clarifies the responsibilities of organizing units, food suppliers, and inspection agencies, providing a scientific and standardized approach to food safety management for large events in Beijing [2] Group 3 - The "Administrative Mediation Service Specification for Consumer Disputes" is the first local standard in China addressing administrative mediation for consumer disputes, detailing service requirements and processes [3] - This standard aims to enhance the efficiency of mediation services and improve the enforcement level of market regulation, contributing to a better consumer environment in Beijing [3] - The "Technical Requirements for Indoor Emergency Shelters in Primary and Secondary Schools" outlines the conversion of schools into emergency shelters without disrupting educational functions, promoting standardized emergency management practices [3]
趋势研判!2025年中国健康管理行业全景分析:市场规模将达到13225.5亿元,具有巨大的市场需求潜力,行业发展前景广阔[图]
Chan Ye Xin Xi Wang· 2025-07-03 01:49
Core Viewpoint - The health management industry in China has shown significant growth over the past two decades, with increasing market demand driven by the public's awareness and self-management of health. The market size is projected to reach 12,555.2 billion yuan in 2024 and approximately 13,225.5 billion yuan in 2025, indicating a robust growth trajectory [1][6][21]. Industry Definition and Necessity - Health management is defined as a comprehensive monitoring and evaluation of individual or group health, providing consultation and intervention to improve health levels. It originated in the late 1950s in the United States, focusing on controlling disease occurrence and reducing medical expenses [2][3][4]. Current Development Status - The health management industry in China has achieved remarkable results, with a projected market size of 12,555.2 billion yuan in 2024, and expected growth to 13,225.5 billion yuan in 2025. The demand for health management services continues to rise as public awareness increases [6][8]. Market Structure - In 2024, the health management market structure is expected to consist of 20.58% from health check-ups, 74.48% from health insurance premiums, and 4.94% from other services. By 2025, these figures are projected to shift to 21.38%, 73.18%, and 5.44%, respectively [8]. Industry Chain - The health management industry chain includes upstream suppliers of software, medical devices, and health monitoring tools, midstream health check-up institutions, and downstream health consulting services targeting individuals, corporate employees, and government agencies [10]. Development Environment and Policies - The concept of health management was introduced in China in the late 20th century, gaining traction with government initiatives like the "Healthy China 2020" strategy. Various policies have been implemented to support the development of the health management industry, emphasizing the importance of health services in economic transformation [12][14]. Competitive Landscape - The health management industry in China is characterized by intense competition, with major players including Meinian Health, Ruici Medical, and various tech companies like Xiaomi and Huawei. The market is diverse, catering to different demographic groups and health management needs [15][17]. Key Companies - Meinian Health focuses on health check-ups and integrates health consulting and intervention services, achieving a revenue of 10.702 billion yuan and a net profit of 282 million yuan in 2024 [17]. - Ruici Medical, a leading health check-up chain, reported a revenue of 2.924 billion yuan and a net profit of 297 million yuan in 2024, emphasizing customized health check-up services [19]. Development Recommendations - The health management industry should focus on building a comprehensive system that includes public hospitals, private chains, and online platforms to enhance service delivery. There is a need for specialized talent in health management, and public awareness campaigns should be intensified to promote health management practices [21][22][25].